rs2066853 — AHR Arg554Lys

Aryl hydrocarbon receptor variant in the transactivation domain that alters AHR signaling, affecting CYP1A2 inducibility, caffeine metabolism patterns, and circadian clock interactions

See your personal result for AHR

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

AHR Arg554Lys — The Receptor That Links Pollutants, Coffee, and Your Clock

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor11 ligand-activated transcription factor
A protein that sits inactive in the cytoplasm until it binds a chemical signal, then travels to the nucleus and switches on target genes best known for its role in detoxifying environmental pollutants such as dioxins and polycyclic aromatic hydrocarbons. But AHR wears many hats: it regulates immune function, gut barrier integrity, and -- critically for this category -- it controls the expression of CYP1A2, the primary liver enzyme responsible for metabolizing caffeine. AHR also directly interacts with the core circadian clock machinery, creating a molecular bridge between environmental chemical exposure, caffeine sensitivity, and sleep-wake regulation.

The rs2066853 variant causes an arginine-to-lysine substitution at position 554 (Arg554Lys, also called R554K) in the transactivation domain of AHR. This domain is where AHR recruits the transcriptional machinery to switch on its target genes, making it a functionally significant location for a coding change.

The Mechanism

AHR resides in the cytoplasm bound to chaperone proteins22 chaperone proteins
HSP90 and XAP2, which keep AHR inactive and properly folded until a ligand arrives. When a ligand binds -- whether a pollutant like dioxin, a dietary compound from cruciferous vegetables, or a tryptophan metabolite -- AHR sheds its chaperones, partners with ARNT33 ARNT
Aryl hydrocarbon receptor nuclear translocator, also known as HIF-1-beta, and translocates to the nucleus. There, the AHR/ARNT heterodimer binds to xenobiotic response elements (XREs)44 xenobiotic response elements (XREs)
DNA sequences in the promoters of AHR target genes, with the core motif 5'-TNGCGTG-3' in the promoters of target genes including CYP1A1 and CYP1A2. The CYP1A2 promoter region alone contains at least 15 AHR response elements, explaining AHR's powerful regulatory control over caffeine metabolism.

The R554K substitution falls in the acidic subdomain of the transactivation domain55 acidic subdomain of the transactivation domain
This region recruits general transcription factors like TATA-binding protein (TBP) to initiate gene transcription. An in silico analysis66 in silico analysis
Ghisari M et al. An in silico approach to investigate the source of the controversial interpretations about the phenotypic results of the human AhR-gene G1661A polymorphism. Environ Int, 2016 found that the Lys554 variant alters protein stability, creates new potential ubiquitination and acetylation sites at nearby residues, and changes the hydropathy pattern at the TBP binding interface. However, the functional consequence is nuanced: an earlier in vitro study by Wong et al.77 in vitro study by Wong et al.
Wong JMY et al. Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro. Pharmacogenetics, 2001 found equivalent ligand binding and CYP1A1 induction between the two variants. The authors of the in silico study suggest that the inherent flexibility of the modular transactivation domain may moderate the SNP's effects in a tissue- and context-dependent manner, potentially explaining why some studies report altered signaling while others do not.

The Evidence

Caffeine consumption. The landmark GWAS meta-analysis by Cornelis et al.88 GWAS meta-analysis by Cornelis et al.
Cornelis MC et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet, 2011 studied 47,341 individuals of European descent and identified the AHR locus on 7p21 as one of only two genome-wide significant determinants of habitual caffeine intake (P = 2.4 x 10-19 for the lead SNP rs4410790). While rs2066853 itself reached P = 0.0004 in this study, the strongest signal mapped upstream of AHR, suggesting that variation in AHR expression level may have a greater impact on caffeine consumption than the coding change alone. The biological logic is clear: AHR controls CYP1A2 expression, and CYP1A2 accounts for approximately 95% of caffeine clearance.

Circadian clock interactions. AHR and the circadian clock share a common structural foundation: both use PAS domains99 PAS domains
Per-Arnt-Sim domains, named after the Drosophila period gene, the AHR nuclear translocator, and the single-minded gene for protein-protein interactions. When activated, AHR competes with CLOCK for binding to BMAL1 -- the obligate partner of CLOCK in driving circadian gene transcription. The resulting AHR/BMAL1 heterodimer represses Per1 transcription1010 represses Per1 transcription
Jaeger C & Tischkau SA. Disruption of CLOCK-BMAL1 transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of Period1 gene. Toxicol Sci, 2010 and dampens circadian rhythm amplitude. A comprehensive review1111 comprehensive review
Tischkau SA. Mechanisms of circadian clock interactions with aryl hydrocarbon receptor signalling. Eur J Neurosci, 2019 documents that AHR activation alters rhythms of feeding, activity, and the hormones melatonin, prolactin, and corticosterone. AHR itself shows rhythmic expression governed by CLOCK/BMAL1 through E-box elements in the AHR promoter, creating a bidirectional regulatory loop.

Disease associations. A meta-analysis of 17 studies1212 meta-analysis of 17 studies
Li H et al. Lack of association between multiple polymorphisms in aryl hydrocarbon receptor gene and cancer susceptibility. Environ Health Prev Med, 2020 encompassing 9,557 cases and 10,038 controls found no overall association between rs2066853 and cancer risk (pooled OR 1.008, 95% CI 0.898-1.131). Individual studies have reported associations with acromegaly (OR ~5 for AA vs GG in Italian patients), coronary artery disease (protective effect of A allele in Chinese, AOR 0.79), and COPD, but these have not been consistently replicated across populations.

Practical Implications

The primary relevance of this variant lies at the intersection of caffeine metabolism and circadian timing. AHR controls CYP1A2 expression, which determines how quickly your body clears caffeine. Individuals whose AHR signaling is altered may experience different patterns of CYP1A2 inducibility -- how readily the enzyme ramps up in response to regular caffeine exposure. Since caffeine has a half-life of 3-7 hours depending on CYP1A2 activity, even modest shifts in inducibility can meaningfully affect sleep quality when coffee is consumed in the afternoon or evening.

The AHR-BMAL1 competition adds another layer: activated AHR dampens circadian rhythm amplitude, which can manifest as weaker sleep-wake contrast, less robust melatonin rhythms, and greater vulnerability to circadian disruption from shift work, jet lag, or irregular schedules. For A allele carriers with potentially altered AHR signaling, paying attention to both caffeine timing and circadian hygiene becomes more important.

Interactions

The most direct interaction is with rs762551 (CYP1A2 *1F). AHR regulates CYP1A2 transcription, so the combination of AHR genotype and CYP1A2 genotype together determines the full picture of caffeine metabolism capacity. Someone with altered AHR signaling (rs2066853 A allele) and the slow-metabolizer CYP1A2 genotype (rs762551 CC) may experience compounded effects on caffeine clearance. The Cornelis et al. GWAS identified both loci as independent genome-wide significant determinants of caffeine consumption, supporting a two-gene model for caffeine metabolism variation.

The interaction with CLOCK (rs1801260) is mechanistic rather than statistical: AHR competes with CLOCK for BMAL1 binding, so AHR activation status directly modulates CLOCK/BMAL1 transcriptional output. This means AHR genotype could theoretically modify the phenotypic impact of CLOCK variants on chronotype, though this specific gene-gene interaction has not been tested in human studies.

Genotype Interpretations

What each possible genotype means for this variant.

GG Standard AHR Signaling Normal

Normal AHR transactivation domain — standard receptor function

The Arg554 (G allele) form of AHR has been the reference against which the Lys554 variant has been compared in functional studies. In vitro assays by Wong et al. (2001) showed that this wild-type receptor has normal ligand binding and transcriptional activation of CYP1A1.

In the Korean case-control study by Kim et al. (2022), the GG genotype showed the strongest synergistic protection from coffee against colorectal cancer risk, with an odds ratio of 0.12 for high coffee consumers. This may reflect normal AHR-mediated induction of CYP1A2 and efficient processing of coffee's bioactive compounds.

Your CYP1A2 inducibility through the AHR pathway follows the standard population pattern, meaning caffeine metabolism is primarily determined by your CYP1A2 genotype (rs762551) rather than AHR variation.

AG Altered AHR Signaling Intermediate

One copy of the Lys554 variant — subtly altered AHR signaling

The heterozygous AG genotype means one of your two AHR copies carries the Lys554 variant. In silico modeling (Ghisari et al. 2016) predicts that the Lys554 substitution alters protein stability and the binding interface for TATA-binding protein in the transactivation domain. However, in vitro studies (Wong et al. 2001) found equivalent receptor function between variants, suggesting the effects may be subtle and dependent on cellular context.

In the Chinese CAD study (Yuan et al. 2015, n = 1,807), heterozygous carriers showed a modestly protective effect (AOR 0.80) compared to GG homozygotes. This and other associations (acromegaly, COPD) have been inconsistently replicated, and the large cancer meta-analysis (Li et al. 2020) found no overall effect, suggesting that rs2066853 modulates risk in combination with environmental exposures rather than acting as an independent risk factor.

For caffeine metabolism, the relevant question is whether your AHR variant affects the inducibility of CYP1A2. While the GWAS by Cornelis et al. found the AHR locus to be a major determinant of caffeine consumption patterns, the strongest signal came from variants affecting AHR expression level rather than the coding change alone. Nonetheless, the Lys554 variant could contribute to individual variation in CYP1A2 regulation.

AA Altered AHR Signaling (Homozygous) Reduced

Two copies of the Lys554 variant — altered AHR transactivation domain

Homozygous AA carriers have both AHR copies carrying the Lys554 substitution. The in silico analysis by Ghisari et al. (2016) predicts altered protein stability, new ubiquitination and acetylation sites near position 554, and changes to the TBP binding interface. With both copies affected, any functional impact of the variant operates without a compensating wild-type allele.

Population-specific studies have reported associations for AA carriers: in an Italian acromegaly cohort (Cannavo et al. 2014, PMID 24521362), rs2066853 was found in 25.7% of patients versus 5.7% of controls. In a Chinese CAD study, the A allele showed a protective association. These disparate findings across different diseases and populations likely reflect AHR's pleiotropic role -- it participates in detoxification, immune regulation, gut barrier function, and circadian timing, with tissue-specific and exposure-dependent effects.

For caffeine and circadian biology, homozygous carriers may have the most pronounced alteration in AHR-mediated CYP1A2 inducibility. Since AHR controls how readily CYP1A2 ramps up in response to regular caffeine intake and other inducers (cruciferous vegetables, charred meat), AA carriers may show different patterns of caffeine tolerance adaptation compared to GG carriers.